EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Study on VEGFA mRNA delivery via GelMA hydrogel-encapsulated extracellular vesicles for enhanced bone regeneration

Shan Li, Yueyang Sheng, Yi You, Ying Wang, Yanzhuo Zhang, Jianfeng Tao, Chengai Wu, Xu Jiang

Materials Today Bio · 2025-10 · 34 · 102144

DOI: 10.1016/j.mtbio.2025.102144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Materials Today Bio, 2025-10. Verfasst von Shan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Orthopaedics, National Center for Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuita…. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Health Commission, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone regeneration remains a clinical challenge due to the inherent limitations of conventional grafts and synthetic materials. While mRNA-based strategies offer promising therapeutic potential, their clinical application is hindered by systemic delivery barriers and rapid degradation. Here, we present a hybrid extracellular vesicle (EV)-GelMA hydrogel system for the localized delivery of VEGFA mRNA to enhance both angiogenesis and osteogenesis through precise spatiotemporal control. In vitro, the VEGFA-EVs-GelMA system significantly enhanced migration and osteogenic differentiation of pre-osteoblastic cells, as evidenced by upregulation of ALP, RUNX2, and OPN expression compared to GelMA controls. In a rat cranial defect model, the VEGFA-EVs-GelMA group showed a marked increase in bone volume/total volume (BV/TV), supported by microcomputed tomography (Micro-CT), at both 4 and 8 weeks post-implantation. Mechanistically, this dual-component platform leverages the biomolecular protection and targeted delivery afforded by EVs, together with the tunable release properties of GelMA hydrogels, to overcome key mRNA delivery barriers. Our results highlight the potential of this system as a clinically translatable strategy for promoting vascularized bone regeneration and provide new insights for the treatment of complex bone defects.

Schlagwörter

Stichwörter der Autor:innen

Bone defectBone tissue engineeringExtracellular vesiclesGelMA hydrogelVEGFA mRNA

Autor:innen und Institutionen

  • Department of Molecular Orthopaedics, National Center for Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
  • Department of Cardiovascular Surgery for the First Affiliated Hospital & Institute for Cardiovascular Science, Suzhou Medical College, Soochow University, Suzhou, China.
  • Department of Orthopaedics, National Center for Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.

Förderung

  • Beijing Municipal Health Commission
  • Beijing Natural Science Foundation

Zitieren

APA

Li, S., Sheng, Y., You, Y., Wang, Y., Zhang, Y., Tao, J., Wu, C., & Jiang, X. (2025). Study on VEGFA mRNA delivery via GelMA hydrogel-encapsulated extracellular vesicles for enhanced bone regeneration. Materials Today Bio, 34, 102144. https://doi.org/10.1016/j.mtbio.2025.102144

Vancouver

Li S, Sheng Y, You Y, Wang Y, Zhang Y, Tao J, et al. Study on VEGFA mRNA delivery via GelMA hydrogel-encapsulated extracellular vesicles for enhanced bone regeneration. Materials Today Bio. 2025;34:102144. doi:10.1016/j.mtbio.2025.102144

BibTeX
@article{Li2025,
  author = {Li, Shan and Sheng, Yueyang and You, Yi and Wang, Ying and Zhang, Yanzhuo and Tao, Jianfeng and Wu, Chengai and Jiang, Xu},
  title = {Study on VEGFA mRNA delivery via GelMA hydrogel-encapsulated extracellular vesicles for enhanced bone regeneration},
  journal = {Materials Today Bio},
  year = {2025},
  volume = {34},
  pages = {102144},
  doi = {10.1016/j.mtbio.2025.102144}
}
Kostenlos starten →